![Big Pharma and Monopoly Capitalism: A Long-term View](/content/images/size/w2000/2023/03/IP_and_Big_Pharma.01--glisse--e-s-.jpg)
Big Pharma and Monopoly Capitalism: A Long-term View
Are IPRs institutions meant to foster innovative activities or conversely to se- cure appropriation and profitability? Taking stock of a long-term empirical evidence on the pharmaceutical sector in the US, we can hardly support IPRs in- tended as an innovation rewarding institution.